Sarcoidosis and lymphoma: a comparative study

• Published in: QJM : An International Journal of Medicine Vol. 108; no. 11; pp. 871 - 878
• Main Authors: Chalayer, É, Bachy, E, Occelli, P, Weiler, L, Faurie, P, Ghesquieres, H, Pavic, M, Broussolle, C, Sève, P
• Format: Journal Article
• Language: English
• Published: England 01.11.2015
• Subjects: Adolescent; Adult; Age of Onset; Aged; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Child; Child, Preschool; Disease-Free Survival; Female; Humans; Infant; Lymphoma - complications; Lymphoma - diagnosis; Lymphoma - drug therapy; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Sarcoidosis - complications; Sarcoidosis - diagnosis; Sarcoidosis - drug therapy; Steroids - therapeutic use; Tomography, X-Ray Computed; Treatment Outcome; Young Adult
• ISSN: 1460-2725; 1460-2393
• DOI: 10.1093/qjmed/hcv039

To assess the clinical features and outcome of lymphoma when associated with sarcoidosis and to determine whether this association gives lymphoma a better prognosis. Multicentre retrospective cohort study. Retrospective chart review. Twenty-one patients were included (9 males, 12 females). Median age at sarcoidosis diagnosis was 48 years (range: 24-68 years). In 14 cases, lymphoma occurred within a previously known sarcoidosis. Five patients received a concomitant diagnosis of sarcoidosis and lymphoma, whereas lymphoma preceded sarcoidosis in two patients. Three patients were diagnosed with Hodgkin's lymphoma and 18 patients with non-Hodgkin's lymphoma (diffuse large B-cell lymphoma (DLBCL) (n = 11), follicular lymphoma (n = 2), chronic lymphocytic leukemia/small lymphocytic lymphoma (n = 2), anaplastic large cell lymphoma ALK + (n = 1), angioimmunoblastic T-cell lymphoma (n = 1) and T-cell prolymphocytic leukemia (n = 1)). Thirteen patients were alive and in complete remission. Median age at the time of diagnosis of sarcoidosis was lower in patients with concomitant lymphoma compared with patients with sarcoidosis preceding lymphoma (34 years vs. 51 years, P = 0.01). Patients presenting with DLBCL associated with sarcoidosis were compared with DLBCL without sarcoidosis. No statistical difference was found in the risk of death or progression between the two groups (P = 0.685). We report here the largest series of lymphoma associated sarcoidosis patients. As opposed to previous studies, we observed a predominance of patients with DLBCL. Our study confirms the concept of the sarcoidosis-lymphoma syndrome. Large B-cell lymphoma does not have a better prognosis when associated with sarcoidosis.